Efforts by President Trump’s team to halt the unstoppable surge in drug prices appear to be paying off, according to several agencies and healthcare officials.

Drug maker Merck, for example, said prices dropped 1.9 percent last year.

According to Adam Schechter, Merck’s president of Global Human Health, the report proves that “the competitive marketplace for pharmaceuticals is working.”

Read more